Neutropenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX

被引：0
|
作者：
Shitara, K. [1 ]
Matsuo, K. [1 ]
Takahari, D. [1 ]
Yokota, T. [1 ]
Ura, T. [1 ]
Muro, K. [1 ]
机构：
[1] Aichi Canc Ctr, Nagoya, Aichi 464, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4115
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A comparison of XELOX with FOLFOX-4 as first-line treatment for metastatic colorectal cancer
    Axel Grothey
    Nature Clinical Practice Oncology, 2009, 6 : 10 - 11
  • [32] A comparison of XELOX with FOLFOX-4 as first-line treatment for metastatic colorectal cancer
    Grothey, Axel
    NATURE CLINICAL PRACTICE ONCOLOGY, 2009, 6 (01): : 10 - 11
  • [33] Controlling Nutritional Status (CONUT) Score Is a Prognostic Marker in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy
    Daitoku, Nobuya
    Miyamoto, Yuji
    Tokunaga, Ryuma
    Sakamoto, Yuki
    Hiyoshi, Yukiharu
    Iwatsuki, Masaaki
    Baba, Yoshifumi
    Iwagami, Shiro
    Yoshida, Naoya
    Baba, Hideo
    ANTICANCER RESEARCH, 2018, 38 (08) : 4883 - 4888
  • [34] A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer
    Xiong, Jian Ping
    Zhang, Ling
    Zhong, Lu Xing
    Qiu, Feng
    Xu, Jun
    Tao, Qing Song
    Xiang, Xiao Jun
    Yu, Feng
    Tang, Xiao Mei
    ANTI-CANCER DRUGS, 2007, 18 (09) : 1103 - 1107
  • [35] BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY FOR THE FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER
    Ubago, R.
    Castillo, M. A.
    Flores, S.
    Beltran, C.
    VALUE IN HEALTH, 2011, 14 (07) : A435 - A435
  • [36] Safety and efficacy of first-line chemotherapy in unresected metastatic colorectal cancer
    Puthillath, Ajithkumar
    Dunn, Kelli Bullard
    Rajput, Ashwani
    Smith, Judy
    Yang, Gary
    Wilding, Gregory E.
    Tan, Wei
    Gupta, Bhavna
    Fakih, Marwan G.
    CLINICAL COLORECTAL CANCER, 2007, 6 (10) : 710 - 715
  • [37] Effect of bevacizumab combined with first-line chemotherapy on metastatic colorectal cancer
    Xiong, Lifeng
    Lou, Yinmei
    Wang, Lin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (04): : 3609 - 3617
  • [38] Significance of chemotherapy induced neutropenia as a prognostic factor in colorectal cancer patients
    An, J. S.
    Kim, K. H.
    ANNALS OF ONCOLOGY, 2015, 26
  • [39] Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer
    Bazarbashi, S.
    Hakoun, A. M.
    Gad, A. M.
    Elshenawy, M. A.
    Aljubran, A.
    Alzahrani, A. M.
    Eldali, A.
    CURRENT ONCOLOGY, 2019, 26 (01) : E24 - E29
  • [40] A Phase II Trial of FOLFOX6 and Cetuximab in the First-line Treatment of Patients With Metastatic Colorectal Cancer
    Boccia, Ralph V.
    Cosgriff, Thomas M.
    Headley, David L.
    Badarinath, Suprith
    Dakhil, Shaker R.
    CLINICAL COLORECTAL CANCER, 2010, 9 (02) : 102 - 107
12345